Lena Johansson, Stress and Alzheimer’s Risk in Women

Lena Johansson, Stress and Alzheimer’s Risk in Women
SHORT FEATURES and FACES ARTICLE

In this recent editorial, Lena Johansson outlines some current concepts and research trends related to the long terms effects of stress and their impact on risk and development of Alzheimer’s disease (AD) in women. Dr. Johansson has authored two population studies – perhaps the first in this area – on the role of midlife stressors and increased risk of dementia in late life.

What drives the stress and AD association is not entirely clear, but the author highlights two possible mechanisms.

The first mechanism discussed is related to glucocorticoids effects on brain and the ‘glucocorticoid cascade hypothesis’, introduced by Robert M. Sapolsky et al., in 1986 and based on two premises: first, that senescence is a form of decreased adaptiveness to stress, and, second, that chronic stress can accelerate the aging process.

Per data from experimental aged animals, it appears that in the aged organism, secretion of adrenocortical glucocorticoids persists even after the stress has ended. Degenerative changes in the region of the brain that normally inhibits glucocorticoid release may be caused by cumulative exposure to glucocorticoids, which in turn switch on feed-forward cascades leading to even higher cortisol secretion from the adrenal gland with further neuronal loss.

The second mechanism is related to the association between chronic stress and hypertension, metabolic syndrome and a dysfunctional immune system, which in turn have been associated with dementia and AD.

Women specifically are more prone to stress-related disorders and have greater associated morbidity; they also react to stress with greater cortisol response, limbic system activation and cytokine activity as compared with men.

In addition, hypothalamic-pituitary-adrenal (HPA) axis responsiveness is greater in women than in men, mostly due to estrogen’s ability to induce corticotropin-releasing hormone gene expression and noradrenergic function (GP. Chrousos, DJ. Torpy and PW. Gold, MD; Ann Intern Med. 1998; 129:229-240).

Recent epidemiological studies have linked stress and AD compellingly. Via the Prospective Population Study of Women, a longitudinal cohort study from Sweden spanning over 30 years, Dr. Johansson and colleagues have shown that long-standing stress in midlife is associated with AD, temporal lobe atrophy and white matter lesions later on, and that experiencing a greater number of psychosocial life stressors is associated with higher incidence of AD.

Also linked to AD in other studies are: parental death during childhood, chronic work-related stress, post-traumatic stress disorder, high neuroticism and anxiety.

The association of stress and AD, while supported by recent evidence, is difficult to delineate well due to the paucity of longitudinal studies. The consequences of chronic stress are a particularly pertinent topic as the average life span increases and our overall population ages. In addition, it is important to recognize the existing gender disparities, in AD as in other illnesses, so as to better understand the neurohormonal processes involved therein.

Source: Expert Rev Neurother, 2014, 14:123-5. doi: 10.1586/14737175.2014.878651.

Read more: Expert Rev Neurother

Note: alz.org, alzheimers.org.uk

You must be logged in to post a comment Login